Get started
Author

Antonio Jimenez Jimenez

Observed names: Antonio M. Jimenez, Antonio M. Jimenez Jimenez, Antonio Martin Jimenez Jimenez
ORCID: 0000-0003-2817-6836
Observed ORCID: 0000-0003-2817-6836
OpenAlex ID: A5031352167
Access: A Multi-Center, Phase II Trial of HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide for Patients with Hematologic Malignancies
2022 · Monzr M. Al Malki, Steven M Devine, et al. · Blood · 6
Observational Comparison of Overall Survival between Phase 1b Orca-T and Registry-Based Post-Transplant Cyclophosphamide Patients
2024 · Caspian H. Oliai, Arpita Gandhi, et al. · Transplantation and Cellular Therapy · 2
Transfusion support after CAR-T cell therapy: Real-world patterns across commercial products and disease groups
2026 · Jay Patel, Denise L. Pereira, et al. · Transfusion Clinique et Biologique · 1
Hematopoietic Cell Transplant Access and Patient Diversity
2026 · Rachel Cusatis, Jianqun Kou, et al. · JAMA Network Open · 1
Cytomegalovirus Lymphadenitis Mimicking Relapsed Lymphoma After CD19 Chimeric Antigen Receptor ( CAR ) T Cell Therapy
2026 · Lubna Osman‐Kardash, Jay Spiegel, et al. · Apmis · 1
PDF
Response to “Revisiting Allogeneic Hematopoietic Cell Donor Selection Guidelines: Umbilical Cord Blood in the PTCy Era”
2026 · Brian C. Shaffer, Stephen R. Spellman, et al. · Transplantation and Cellular Therapy · 1
Salvage of primary graft failure with allogeneic hematopoietic stem cell transplantation from a deceased organ donor: report of a novel graft source
2026 · Noa G. Holtzman, Matthew Muthiah, et al. · Haematologica
PDF
Erratum: Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
2026 · Monzr M. Al Malki, Stephanie Bo-Subait, et al. · Journal of Clinical Oncology
Phase II Study of Posttransplant Cyclophosphamide‐Based Graft‐Versus‐Host Disease Prophylaxis After HLA ‐Mismatched Unrelated Donor Reduced Intensity Transplantation: Results From the ACCESS Trial Expansion Cohort
2026 · Brian C. Shaffer, Monzr M. Al Malki, et al. · American Journal of Hematology
PDF
POSTER: CT-594: Clinical Overview of Infection Events With Orca-T vs Conventional Allogeneic Hematopoietic Stem Cell Transplantation in the Precision-T Phase 3 Study
2026 · Roni Tamari, Caspian Oliai, et al. · Clinical Lymphoma Myeloma & Leukemia
CT-594: Clinical Overview of Infection Events With Orca-T vs Conventional Allogeneic Hematopoietic Stem Cell Transplantation in the Precision-T Phase 3 Study
2026 · Roni Tamari, Caspian Oliai, et al. · Clinical Lymphoma Myeloma & Leukemia
Dasatinib Exposure and Risk of CMV Reactivation in Philadelphia Chromosome‐Positive Acute Lymphoblastic Leukemia
2026 · Lubna Osman‐Kardash, Ahmed Alnajar, et al. · American Journal of Hematology
PDF
Infection burden in mismatched unrelated donor hematopoietic cell transplantation: results from the ACCESS trial
2026 · Jeffery J. Auletta, Joseph Stanek, et al. · Blood Advances
Day‐30 IL1RL1 , CXCL9 and REG3α are prognostic for survival after mismatched unrelated donor transplantation
2026 · Trent Wang, Anna C. Ferreira, et al. · British Journal of Haematology
Infection Burden in Mismatched Unrelated Donor Hematopoietic Cell Transplantation Using Standard-Dose Post-Transplantation Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis: Insights from the NMDP-Sponsored, CIBMTR-Led ACCESS Trial
2026 · Dr. Jeffery J. Auletta, Joseph Stanek, et al. · Transplantation and Cellular Therapy
Clinical Outcomes in Orca-T and Registry-Based Post-Transplant Cyclophosphamide Patients: An Observational Comparison
2026 · Amandeep Salhotra, Roni Tamari, et al. · Transplantation and Cellular Therapy
Mismatch Doesn't Mean Misfortune: Quality of Life after HCT in the ACCESS Trial
2026 · Rachel Cusatis, Jianqun Kou, et al. · Transplantation and Cellular Therapy
Clinical Outcomes in Myelodysplastic Syndrome Patients Treated with Orca-T or Post-Transplant Cyclophosphamide Patients: A Registry-Based Comparison
2026 · Sagar S. Patel, Caspian Oliai, et al. · Transplantation and Cellular Therapy
Extracorporeal Photopheresis for Chronic Graft‐Versus‐Host Disease According to 2014 NIH Consensus Criteria
2025 · Yitzhar Goretsky, Noa Holtzman, et al. · Journal of Clinical Apheresis
Access: A Multi-Center, Phase II Trial of HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide for Patients with Hematologic Malignancies
2023 · Monzr M. Al Malki, Brian C. Shaffer, et al. · Transplantation and Cellular Therapy
A Multi-Center Collaborative Study of Outcomes of TP53-Mutated MDS/AML Patients Following Allogeneic HCT
2022 · Michael Byrne, Tony Kurian, et al. · Transplantation and Cellular Therapy
Works count: 21
Citation count: 12
H-index: 2
I10-index:
Year
Topic
Type